These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32322420)

  • 1. Targeted next generation sequencing identifies somatic mutations in a cohort of Egyptian breast cancer patients.
    Nassar A; Abouelhoda M; Mansour O; Loutfy SA; Hafez MM; Gomaa M; Bahnassy A; El-Din Youssef AS; Lotfy MM; Ismail H; Ahmed OS; Abou-Bakr AA; Zekri AN
    J Adv Res; 2020 Jul; 24():149-157. PubMed ID: 32322420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multigene Panel Sequencing Reveals Cancer-Specific and Common Somatic Mutations in Colorectal Cancer Patients: An Egyptian Experience.
    Youssef ASE; Abdel-Fattah MA; Lotfy MM; Nassar A; Abouelhoda M; Touny AO; Hassan ZK; Mohey Eldin M; Bahnassy AA; Khaled H; Zekri ARN
    Curr Issues Mol Biol; 2022 Mar; 44(3):1332-1352. PubMed ID: 35723313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic Mutations Alter Interleukin Signaling Pathways in Grade II Invasive Breast Cancer Patients: An Egyptian Experience.
    Nassar A; Zekri ARN; Elberry MH; Lymona AM; Lotfy MM; Abouelhoda M; Youssef ASE
    Curr Issues Mol Biol; 2022 Nov; 44(12):5890-5901. PubMed ID: 36547062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supratentorial Sporadic Hemangioblastoma: A Case Report With Mutation Profiling Using Next-Generation DNA Sequencing.
    Taher MM; Bantan NA; Alwalily MH; Saeed M; Taher NM; Bouzidi M; Jastania RA; Balkhoyour KB
    Cureus; 2023 Jun; 15(6):e39818. PubMed ID: 37273678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
    Li G; Guo X; Chen M; Tang L; Jiang H; Day JX; Xie Y; Peng L; Xu X; Li J; Wang S; Xiao Z; Dai L; Wang J
    PLoS One; 2018; 13(9):e0203495. PubMed ID: 30212483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of activating mutations in liquid biopsy of Egyptian breast cancer patients using targeted next-generation sequencing: a pilot study.
    Kassem N; Kassem H; Kassem L; Hassan M
    J Egypt Natl Canc Inst; 2021 Apr; 33(1):10. PubMed ID: 33864517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
    Liu X; Mody K; de Abreu FB; Pipas JM; Peterson JD; Gallagher TL; Suriawinata AA; Ripple GH; Hourdequin KC; Smith KD; Barth RJ; Colacchio TA; Tsapakos MJ; Zaki BI; Gardner TB; Gordon SR; Amos CI; Wells WA; Tsongalis GJ
    Clin Chem; 2014 Jul; 60(7):1004-11. PubMed ID: 24821835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1, BRCA2, TP53, PIK3CA, PTEN and AKT1 genes mutations in Burkina Faso breast cancer patients: prevalence, spectrum and novel variant.
    Ouedraogo SY; Zoure AA; Zeye MMJ; Kiendrebeogo TI; Zhou X; Sawadogo AY; Simpore J; Chen H
    Mol Genet Genomics; 2022 Sep; 297(5):1257-1268. PubMed ID: 35731312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of genetic mutations in patients with breast cancer from Saudi Arabia using Ion AmpliSeq™ Cancer Hotspot Panel v.2.0.
    Messaoudi SA; Al Sharhan NA; Alharthi B; Babu SR; Alsaleh AB; Alasiri AM; Assidi M; Buhmeida A; Almawi WY
    Biomed Rep; 2022 Apr; 16(4):26. PubMed ID: 35251613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline and Somatic mutations in postmenopausal breast cancer patients.
    Nagy TR; Maistro S; Encinas G; Katayama MLH; Pereira GFL; Gaburo-Júnior N; Franco LAM; Gouvêa ACRC; Diz MDPE; Leite LAS; Folgueira MAAK
    Clinics (Sao Paulo); 2021; 76():e2837. PubMed ID: 34287479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study.
    Shah OS; Soran A; Sahin M; Knapick BA; Ugras S; Celik E; Lucas PC; Lee AV
    Clin Breast Cancer; 2021 Jun; 21(3):210-217. PubMed ID: 33191115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of a novel panel of 24 genes with high frequencies of mutation in gastric cancer based on next-generation sequencing.
    Zeng HH; Yang Z; Qiu YB; Bashir S; Li Y; Xu M
    World J Clin Cases; 2022 May; 10(15):4761-4775. PubMed ID: 35801059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in
    Szpechcinski A; Szolkowska M; Winiarski S; Lechowicz U; Wisniewski P; Knetki-Wroblewska M
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers.
    Muller KE; Marotti JD; de Abreu FB; Peterson JD; Miller TW; Chamberlin MD; Tsongalis GJ; Tafe LJ
    Exp Mol Pathol; 2016 Jun; 100(3):421-5. PubMed ID: 27095739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
    Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
    Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes.
    Kim JY; Lee E; Park K; Park WY; Jung HH; Ahn JS; Im YH; Park YH
    Oncotarget; 2017 Apr; 8(17):27997-28007. PubMed ID: 28427202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive multigene mutation spectra of breast cancer patients from Northeast China obtained using the Ion Torrent sequencing platform.
    Fan C; Liu N; Fan S; Yang Z; Ye N; Wang K
    Oncol Rep; 2019 Oct; 42(4):1580-1588. PubMed ID: 31364747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer.
    Pradella LM; Evangelisti C; Ligorio C; Ceccarelli C; Neri I; Zuntini R; Amato LB; Ferrari S; Martelli AM; Gasparre G; Turchetti D
    BMC Cancer; 2014 Feb; 14():70. PubMed ID: 24498881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mutational profiles between triple-negative and hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancers in T2N0-1M0 stage: Implications of TP53 and PIK3CA mutations in Korean early-stage breast cancers.
    Lee S; Kim HY; Jung YJ; Jung CS; Im D; Kim JY; Lee SM; Oh SH
    Curr Probl Cancer; 2022 Apr; 46(2):100843. PubMed ID: 35180531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.